Infezioni da Herpes virus

Informazioni cliniche

La famiglia degli herpesvirus comprende più di 100 tipi di virus diversi, otto dei quali possono causare infezioni nell'uomo. Questi cosiddetti herpesvirus umani comprendono il virus Herpes simplex di tipo 1 e 2 (HSV-1 e -2), il virus varicella-zoster (VZV), il virus Epstein-Barr (EBV), il Citomegalovirus (CMV), gli herpesvirus umani 6 e 7 (HHV-6 e -7) e l'herpesvirus umano 8 (HHV-8), associato al sarcoma di Kaposi. Nonostante le grandi somiglianze strutturali tra i diversi patogeni, l'infezione da herpesvirus può causare malattie molto diverse tra loro, ad esempio l'herpes labiale o genitale, la varicella, il fuoco di Sant‘Antonio, la malattia del bacio o diversi tipi di cancro. Durante la gravidanza, soprattutto l'infezione primaria con particolari herpesvirus può portare a gravi lesioni o addirittura alla perdita del bambino. Attualmente esiste solo un vaccino contro il VZV. Dopo l'infezione primaria, che spesso procede in modo asintomatico, gli herpesvirus persistono per tutta la vita nell'organismo in uno stato latente e possono riattivarsi in un momento successivo, ad esempio a causa di un sistema immunitario indebolito, e causare (di nuovo) sintomi.

Diagnostica

La diagnostica di laboratorio degli herpesvirus si basa su metodi di rilevamento diretti o indiretti. I metodi diretti, che sono particolarmente importanti per la diagnosi di infezioni acute o in persone immunodepresse, includono, ad esempio, la coltura del virus o i test basati sulla PCR, in cui vengono rilevati gli acidi nucleici virali. Come materiale di campionamento si utilizzano: liquido vescicolare, strisci di pelle o di mucosa, sangue, liquor o liquido di lavaggio broncoalveolare. Se l'anticorpo specifico per l'herpesvirus viene rilevato nel siero, nel plasma o nel liquor del paziente, questo viene considerato un rilevamento indiretto del patogeno. La rilevazione degli anticorpi non solo consente di trarre conclusioni su quale virus sia presente nel paziente, ma può anche contribuire alla differenziazione di infezioni primarie e ricorrenti. EUROIMMUN offre un'ampia gamma di prodotti per la rilevazione delle infezioni da herpesvirus, che comprendono sia la rilevazione degli anticorpi che i metodi di rilevazione diretta.

 

Troverete altri test per la diagnosi delle infezioni da Herpes virus offerti da GeneProof (distribuiti da Euroimmun) qui.


Products

Filter techniques:

Method
Parameter
Substrate
Species
ChLIA
Anti-Herpes simplex virus 1 ChLIA (IgG)
Antigen-coated magnetic particles
WESTERNBLOT
antibodies against Herpes simplex virus (HSV)
IgG positive control
ChLIA
Control set Anti-HSV 1 ChLIA (IgG)
2 x 0.5 ml control 1/2
ELISA
CSQ pair of controls
anti-HSV-1/2 Pool (IgG)
ELISA
Anti-HSV-1/2 Pool ELISA (IgG)
herpes simplex virus
native antigens from HSV-1 and HSV-2
antigen-coated
microplate wells
ELISA
CSF: Anti-HSV-1/2 Pool ELISA (IgG)
herpes simplex virus
Sample type: CSF/serum pair
antigen-coated
microplate wells
ELISA
Anti-HSV-1/2 Pool ELISA (IgM)
herpes simplex virus
native antigens from HSV-1 and HSV-2
antigen-coated
microplate wells
WESTERNBLOT
Anti-HSV-1 / HSV-2 gG-2 EUROLINE-WB (IgG)
Herpes simplex virus 1 (HSV-1) plus HSV-2 type-specific glycoprotein G2
Westernblot
WESTERNBLOT
Anti-HSV-1 / HSV-2 gG-2 EUROLINE-WB (IgM)
Herpes simplex virus 1 (HSV-1) plus HSV-2 type-specific glycoprotein G2
Westernblot
ChLIA
IDS HSV 1/2 IgM
gG1 and gG2 antigens 1
antigenic coated magnetic particles
ChLIA
IDS HSV 1/2 IgM Control Set 1
3 x 1.5 ml Control 1/2
ELISA
Anti-HSV-1 (gC1) ELISA (IgG)
herpes simplex virus 1
recombinant glycoprotein C1 from HSV-1
antigen-coated
microplate wells
ChLIA
IDS HSV-1 IgG
gG1 antigen 1
antigenic coated magnetic particles
ChLIA
Anti-Herpes simplex virus 2 ChLIA (IgG)
Antigen-coated magnetic particles
ChLIA
Control set Anti-HSV 2 ChLIA (IgG)
2 x 0.5 ml control 1/2
ELISA
Anti-HSV-2 (gG2) ELISA (IgG)
herpes simplex virus 2
recombinant glycoprotein G2 from HSV-2
antigen-coated
microplate wells
ChLIA
IDS HSV-2 IgG
gG2 antigen 1
antigenic coated magnetic particles
ChLIA
IDS HSV 1/2 IgG Control Set 1
3 x 1.5 ml Control 1/2
IIFT
HHV-6
infected cells
EU 30
IIFT
HHV-6 EUROPattern
infected cells
EU 30
EUROLINE
positive control serum: IgG, human, 50x concentrated
for CMV
EUROLINE
positive control serum: IgM, human, 50x concentrated
for CMV
ELISA
Anti-CMV ELISA (IgG)
cytomegalovirus
antigen-coated
microplate wells
ELISA
Anti-CMV ELISA (IgM)
cytomegalovirus
antigen-coated
microplate wells
ChLIA
IDS CMV IgG 1
antigenic coated magnetic particles
ChLIA
IDS CMV IgM 1
antigenic coated magnetic particles
ChLIA
IDS CMV Control Set 1
3 x 1.5 ml Control 1/2
ELISA
Avidity: Anti-CMV ELISA (IgG)
cytomegalovirus
avidity determination
antigen-coated
microplate wells
ChLIA
IDS CMV IgG Avidity 1
antigenic coated magnetic particles
ChLIA
IDS CMV Avidity Control Set 1
3 x 1.0 ml Control 1/2
EUROLINE
EUROLINE Anti-CMV (IgM)
EUROLINE
EUROLINE
EUROLINE Anti-CMV (IgG)
EUROLINE
ELISA
Anti-CMV p52 ELISA (IgM)
cytomegalovirus
p52 antigen from CMV
antigen-coated
microplate wells
ELISA
Anti-CMV gB ELISA (IgG)
cytomegalovirus glycoprotein B
glycoprotein B antigen from CMV
antigen-coated
microplate wells
ELISA
CSQ pair of controls
anti-Cytomegalovirus (IgG)
ELISA
CSF: Anti-CMV ELISA (IgG)
cytomegalovirus
Sample type: CSF/serum pair
antigen-coated
microplate wells
IIFT
Varicella zoster virus
(VZV)
infected cells
EU 168
ELISA
Anti-VZV ELISA (IgA)
Varicella zoster virus
antigen-coated
microplate wells
ELISA
Anti-VZV ELISA (IgG)
Varicella zoster virus
antigen-coated
microplate wells
ELISA
Anti-VZV ELISA (IgM)
Varicella zoster virus
antigen-coated
microplate wells
ChLIA
IDS VZV IgG 1
antigenic coated magnetic particles
ChLIA
IDS VZV IgM 1
antigenic coated magnetic particles
ELISA
Avidity: Anti-VZV ELISA (IgG)
Varicella zoster virus
avidity determination
antigen-coated
microplate wells
ELISA
Anti-VZV Glycoprotein ELISA (IgM)
Varicella zoster virus
antigen-coated
microplate wells
ELISA
Anti-VZV ELISA 2.0 (IgG)
Varicella zoster virus
antigen-coated
microplate wells
ELISA
CSQ pair of controls
anti-VZV (IgG)
ChLIA
IDS MMV IgG Control Set 1
3 x 1.5 ml Control 1/2
ChLIA
IDS MMV IgM Control Set 1
3 x 1.5 ml Control 1/2
MICROBLOT
EUROMicroblot Anti-EBV (IgM)
MICROBLOT
EUROMicroblot Anti-EBV (IgG)
EUROLINE
positive control serum: IgG, human, 50x concentrated
for EBV-Profil 2 G
EUROLINE
positive control serum: IgM, human, 50x concentrated
for EBV-Profil 2 M
EUROLINE
EUROLINE Anti-EBV Profile 2 (IgG)
(VCA gp125, VCA p19,
EBNA-1, p22, EA-D separately)
EUROLINE
EUROLINE
EUROLINE Anti-EBV Profile 2 (IgM)
(VCA gp125, VCA p19,
EBNA-1, p22, EA-D separately)
EUROLINE
IIFT
Epstein-Barr
virus capsid antigen
(EBV-CA)
expressing cells
P3HR1
ELISA
Anti-EBV-CA ELISA (IgA)
Epstein-Barr virus capsid antigen
antigen-coated
microplate wells
ELISA
Anti-EBV-CA ELISA (IgG)
Epstein-Barr virus capsid antigen
antigen-coated
microplate wells
ELISA
Anti-EBV-CA ELISA (IgM)
Epstein-Barr virus capsid antigen
antigen-coated
microplate wells
ChLIA
Anti-EBV-CA ChLIA (IgG)
Epstein-Barr virus capsid antigen
Antigen-coated magnetic particles
ChLIA
Anti-EBV-CA ChLIA (IgM)
Epstein-Barr virus capsid antigen
Antigen-coated magnetic particles
ChLIA
Control set Anti-EBV-CA ChLIA (IgG)
Epstein-Barr virus capsid antigen
2 x 0.5 ml control 1/2
ChLIA
Control set Anti-EBV-CA ChLIA (IgM)
Epstein-Barr virus capsid antigen
2 x 0.5 ml control 1/2
ChLIA
IDS EBV VCA IgG
Epstein-Barr virus capsid antigen 1
antigenic coated magnetic particles
ChLIA
IDS EBV VCA IgM
Epstein-Barr virus capsid antigen 1
antigenic coated magnetic particles
ELISA
Avidity: Anti-EBV-CA-ELISA (IgG)
Epstein-Barr virus capsid antigen
avidity determination
antigen-coated
microplate wells
ELISA
CSQ pair of controls
anti-EBV-CA (IgG)
ELISA
CSF: Anti-EBV-CA-ELISA (IgG)
Epstein-Barr virus capsid antigen
Sample type: CSF/serum pair
antigen-coated
microplate wells
IIFT
Epstein-Barr virus
nuclear antigen (EBNA,
complement-fixing antibodies)
expressing cells
Raji
ELISA
Anti-EBNA-1 ELISA (IgG)
Epstein-Barr virus nuclear antigen
antigen-coated
microplate wells
ChLIA
Anti-EBNA-1 ChLIA (IgG)
Epstein-Barr virus nuclear antigen
Antigen-coated magnetic particles
ChLIA
Control set Anti-EBNA-1 ChLIA (IgG)
Epstein-Barr virus nuclear antigen
2 x 0.5 ml control 1/2
ChLIA
IDS EBV EBNA-1 IgG
Epstein-Barr virus nuclear antigen 1
antigenic coated magnetic particles
IIFT
Epstein-Barr
virus early antigen
(EBV-EA)
expressing cells
EU 33
ELISA
Anti-EBV-EA-D ELISA (IgA)
Epstein-Barr virus early antigen
antigen-coated
microplate wells
ELISA
Anti-EBV-EA-D ELISA (IgG)
Epstein-Barr virus early antigen
antigen-coated
microplate wells
ELISA
Anti-EBV-EA-D ELISA (IgM)
Epstein-Barr virus early antigen
antigen-coated
microplate wells
ChLIA
IDS EBV EA IgG
EA-D antigen 1
antigenic coated magnetic particles
ChLIA
IDS EBV Control Set 1
3 x 1.5 ml Control 1/2
IIFT
BIOCHIP
Sequence EBV
fields A and B: EBV-CA (IgG)
field C: EBV-CA (IgM)
field D: EBV-EA
field E: EBNA


expressing cells
expressing cells
expressing cells
expressing cells


P3HR1
P3HR1
EU 33
Raji
IIFT
EUROPLUS
BIOCHIP Sequence EBV
field A: EBV-CA (IgG), gp125 ag, p19 ag

field B: EBV-CA (IgG)
field C: EBV-CA (IgM), gp125 ag, p19 ag

field D: EBV-EA
field E: EBNA


expr. cells, gp125/p19/
ag-free BIOCHIP
expressing cells
expressing cells
expr. cells, gp125/p19/
ag-free BIOCHIP
expressing cells


P3HR1, native/rec.
EU 120
P3HR1
P3HR1, native/rec.
EU 120
EU 33
Raji
1Product manufactured by third party. Please contact your local Euroimmun representative for more information.
Back to top

Comunicazione destinata esclusivamente a professionisti sanitari


AccettoNon accetto